News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Despite Repeated Rebuffs, Teva Pharmaceutical Industries Limited (TEVA) Woos Cipla Ltd. With $6 Billion Offer


5/8/2014 6:25:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

It’s the season for pharma deals, and the world’s largest maker of off-patent drugs, Israel’s Teva Pharmaceutical Industries Ltd, is wooing Cipla Ltd with an offer that is as high as $6 billion, people familiar with the matter said. The Israeli company, which is targeting revenue of $31 billion by 2015 (it also wants to reduce costs by $2 billion in the next two to three years) has since 2012 twice made approaches to the Indian drug maker. It was rebuffed both times.

Help employers find you! Check out all the jobs and post your resume.

Read at Live Mint
Read at BusinessWeek

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES